Navigation Links
Clinical trial looks to improve pancreatic cancer survival rates
Date:2/12/2013

AUGUSTA, Ga.Researchers at Georgia Regents University Cancer Center are investigating a new avenue of treatment to help boost poor pancreatic cancer survival rates.

The treatment combines a standard chemotherapy drug with a monoclonal antibody that may help the immune system fight pancreatic cancer.

Every year, nearly 44,000 patients are diagnosed with pancreatic cancer and more than 37,000 die from the diseaseincluding well-known figures such as Patrick Swayze, Margaret Mead and Luciano Pavarotti.

Despite increased public attention, the disease remains one of the deadliest forms of cancer because it tends to be symptom-free at its earliestand most treatablestages. Overall five-year survival rates are a dismal 5.6 percent.

Patients treated with surgery typically see their cancers recur within about seven months. Coupling surgery with the chemotherapy drug Gemcitabine in eligible patients extends disease-free survival to a little over 13 months. Now, researchers are turning to combination therapies to improve these rates, coupling chemotherapy with drugs that enhance the immune system's ability to fight cancer.

"One of the reasons cancer can be so difficult to treat is the fact that the immune system often doesn't recognize tumor cells as cancer, or the tumors themselves express substances to suppress the immune system," said GRU Cancer Center Director Samir N. Khleif. "Immunotherapy is considered to be an important approach since it targets those specific substances in order to establish a more effective response against cancer."

Promise has already been shown in monoclonal antibodies that fight cancer's ability to evade the immune system, said Khleif, who is the principal investigator on a pilot study combining Gemcitabine with a monoclonal antibody called CT-011 in certain pancreatic cancer patients who have been treated with surgery.

In animal models, CT-011 has been shown to inhibit
'/>"/>

Contact: Danielle Moores
dwongmoores@yahoo.com
706-496-5956
Georgia Health Sciences University
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. First targeted nanomedicine to enter human clinical studies
2. Clinical insight improves treatment with new lung cancer drug
3. Clinical news alert from the American Academy of Orthopaedic Surgeons
4. NYU Langone experts present research, clinical advances at neurosurgeons meeting
5. Kroenke honored for outstanding contributions in clinical research training
6. Awards celebrate clinical research that can improve health and alleviate suffering
7. Association for Psychological Science, SAGE launch Clinical Psychological Science
8. URMC clinical trial tests new regimen for hypertension
9. Analysis Finds Clinical Trials Often Small, of Poor Quality
10. Automated insulin dosage titration system demonstrates positive clinical study results
11. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clinical trial looks to improve pancreatic cancer survival rates
(Date:11/21/2014)... CARE Surrogacy Center in Mexico is ... at the same time enhancing their surrogacy journey with high ... parents across the globe, the company is reporting on its ... zoning in on the skyrocketing costs of surrogacy — and ... over-stressing clinical success rates ? , Fertility clinics ...
(Date:11/21/2014)... 2014 Nature’s Sleep is excited to announce the ... contest calls for the creation of any type of art — ... encompasses sleep, a bed or a mattress. , “We had ... Vice President of Marketing for Nature’s Sleep, “that we decided to ... than 10,000 creative entries from some very talented artists all the ...
(Date:11/21/2014)... Dennis Thompson HealthDay Reporter ... gel into the wall of a still-beating heart has the ... failure, according to a new study. Heart patients who ... were able to walk hundreds of feet farther during a ... is chief of the cardiovascular division at Washington University School ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. ... excess or binge drink are not alcoholics, a new U.S. ... who drink too much aren,t dependent on alcohol. But one ... Centers for Disease Control and Prevention. , , "A lot of ... alcoholics," said study co-author Dr. Robert Brewer, the leader of ...
(Date:11/18/2014)... Massachusetts (PRWEB) November 18, 2014 ... on the development and commercialization of specialized drug ... Office has granted Cristcot a patent for the ... applicator, Sephure®. , The patent was ... the property rights have been assigned to Cristcot ...
Breaking Medicine News(10 mins):Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3Health News:Nature’s Sleep Kicks Off their 2nd Art Of Sleep Contest 2Health News:Gel Implant Might Help Fight Heart Failure 2Health News:Gel Implant Might Help Fight Heart Failure 3Health News:Many People Who Drink a Lot Aren't Alcoholics: CDC 2Health News:Many People Who Drink a Lot Aren't Alcoholics: CDC 3Health News:Japanese Patent Office Grants Patent to Cristcot Inc. 2
... been 18 excruciating hours since you last had one. You,re ... only one thing you can think about firing up ... of Western Ontario researchers have been hard at work trying ... Director of Western,s new Exercise and Health Psychology Laboratory, and ...
... UC Irvine cardiologists have found a pouchlike structure inside ... source of stroke-causing blood clots. About 80 percent of ... due to blood clots blocking a brain artery. In up ... be determined. Study co-author Dr. Subramaniam Krishnan said the discovery ...
... to ,less than, ,greater than, problems, study suggests , ... monkey do simple math? , A German team of ... abstract mathematical reasoning using specific brain cells dedicated to ... finding could provide insight into the neurology behind human ...
... ... headquarters to a larger facility to better serve their customers. , ... Farmingdale, NY (PRWEB) January 19, 2010 ... Labs, reputation for outstanding customer service, contributed to a rapid growth in sales for ...
... Society Supports Additional Scientific Studies, Fights Negative Backlash From ... Possibly Places Patients With Osteoporosis in Jeopardy of Losing ... , Jan. 19 Given the current ... by interventional radiologists in individuals with painful osteoporotic vertebral ...
... , NEW YORK , Jan. 19 ... employees reap the operating efficiencies and service advantages of technology ... of America (Guardian) , a leading provider of employee ... focusing on its self-service benefits website, Guardian Anytime. , Guardian,s ...
Cached Medicine News:Health News:Sweating out the cravings 2Health News:Monkey Brain 'Hardwired' for Simple Math 2Health News:Monkey Brain 'Hardwired' for Simple Math 3Health News:Nutricap Labs Energizes 2010 with Move to More Advanced GMP Certified Facility 2Health News:Society of Interventional Radiology Supports Treatment for Painful Spine Fractures: Patient Selection Key 2Health News:Society of Interventional Radiology Supports Treatment for Painful Spine Fractures: Patient Selection Key 3Health News:Society of Interventional Radiology Supports Treatment for Painful Spine Fractures: Patient Selection Key 4Health News:Society of Interventional Radiology Supports Treatment for Painful Spine Fractures: Patient Selection Key 5Health News:Society of Interventional Radiology Supports Treatment for Painful Spine Fractures: Patient Selection Key 6Health News:Guardian Launches Campaign to Bolster Use of Web Capabilities to Advance Green Initiatives and Enhance Service 2Health News:Guardian Launches Campaign to Bolster Use of Web Capabilities to Advance Green Initiatives and Enhance Service 3Health News:Guardian Launches Campaign to Bolster Use of Web Capabilities to Advance Green Initiatives and Enhance Service 4
(Date:11/18/2014)... and SAN DIEGO , ... HPPI), a clinical stage biopharmaceutical company that discovers, ... patients with cancer, announced today that it filed ... U.S. Food and Drug Administration (FDA) on Friday, ... covers HPPI,s proposed clinical development of a patented ...
(Date:11/18/2014)... 2014  TransCelerate BioPharma Inc. ("TransCelerate") announces ... on Risk-Based Monitoring (RBM), " Evaluating Source ... in Clinical Trials ," in the Drug ... Science  (TIRS) journal. Developed by TransCelerate,s 19 ... manuscript examines the value of Source Data ...
(Date:11/18/2014)... SynCardia Systems, Inc., has been recognized with ... Companies presented by the Arizona Technology Council in conjunction ... annual Governor,s Celebration of Innovation Awards honor technology and ... Arizona Governor Jan Brewer ... honored for its Freedom® portable driver, which powers the ...
Breaking Medicine Technology:HedgePath Pharmaceuticals Files IND Application 2HedgePath Pharmaceuticals Files IND Application 3HedgePath Pharmaceuticals Files IND Application 4TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 3
... the battle is ... far from won, ... patients with blood cancers. Sixty years ago there,were few effective treatments for ... low. Today, about 75 percent of children with,acute leukemia and nearly 80 ...
... Inc. (OTC,Bulletin Board: GOVX), an Atlanta based biotechnology ... for its HIV/AIDS,vaccines at the AIDS Vaccine 2007 ... GeoVax HIV/AIDS human trial results were presented by ... Prime followed by Recombinant MVA Boost,is Well Tolerated ...
Cached Medicine Technology:September is Leukemia, Lymphoma and Myeloma Awareness Month 2GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference 2GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference 3GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference 4
... For more than 20 years, ... our various healthcare and industrial clients ... Quality, Accuracy, Convenience, Speed, and Economy. ... to remain focused on the individual ...
... Established in 1979, ... testing services in the ... Wellness, Insurance, Clinical Trials ... under one roof at ...
Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...
PhenoPath Laboratories provides screening, diagnostic, and prognostic testing services to hospitals, physician offices, surgery centers, biopharmaceutical companies and research institutions nationwi...
Medicine Products: